Federated Hermes, Inc. Mannkind Corp Transaction History

Federated Hermes, Inc.

$43.6 Billion
Q3 2024

A detailed history of Federated Hermes, Inc. transactions in Mannkind Corp stock. As of the latest transaction made, Federated Hermes, Inc. holds 1,904,281 shares of MNKD stock, worth $13.1 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,904,281

Previous 1,883 101030.16%

Holding current value

$13.1 Million

Previous $9,000 132766.67%

% of portfolio

0.03%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$5.01 - $6.7 $9.53 Million - $12.7 Million	1,902,398 Added 101030.16%	1,904,281 $12 Million
Q2 2024 Aug 08, 2024	BUY	$4.05 - $5.43 $5,200 - $6,972	1,284 Added 214.36%	1,883 $9,000
Q1 2024 May 14, 2024	BUY	$3.25 - $5.27 $1,946 - $3,156	599 New	599 $2,000
Q4 2022 Feb 13, 2023	BUY	$3.02 - $5.37 $211 - $375	70 Added 7000.0%	71 $0
Q3 2022 Nov 14, 2022	BUY	$2.99 - $4.35 $2 - $4	1 New	1 $1,000
Q2 2022 Aug 15, 2022	SELL	$2.67 - $4.77 $5 - $9	-2 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$2.62 - $4.45 $266,831 - $453,205	-101,844 Reduced 100.0%	2 $1,000
Q4 2021 Feb 14, 2022	SELL	$4.05 - $5.37 $388 - $515	-96 Reduced 0.09%	101,846 $445,000
Q3 2021 Nov 15, 2021	BUY	$3.89 - $5.48 $373 - $526	96 Added 0.09%	101,942 $443,000
Q2 2021 Aug 16, 2021	SELL	$3.61 - $5.45 $445,376 - $672,382	-123,373 Reduced 54.78%	101,846 $555,000
Q1 2021 May 13, 2021	BUY	$3.14 - $6.14 $404,444 - $790,856	128,804 Added 133.59%	225,219 $883,000
Q4 2020 Feb 12, 2021	BUY	$1.79 - $4.04 $171,426 - $386,906	95,769 Added 14824.92%	96,415 $302,000
Q2 2020 Aug 13, 2020	BUY	$0.94 - $2.21 $607 - $1,427	646 New	646 $1,000
Q2 2019 Aug 14, 2019	SELL	$1.09 - $1.88 $1,468 - $2,532	-1,347 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$1.14 - $2.25 $1,535 - $3,030	1,347 New	1,347 $3,000

Others Institutions Holding MNKD

# of Institutions

245

Shares Held

148M

Call Options Held

1.62M

Put Options Held

802K

View Full List

About MANNKIND CORP

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.77B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

More about MNKD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Mannkind Corp Transaction History